title: Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine.
abstract: Forty-four vaccinees immunized with rabies vaccine and human rabies immunoglobulin according to the abbreviated intramuscular regimen (the 2-1-1 schedule) were followed-up after 1100 days and had their blood samples taken. The persistence of rabies neutralizing antibody was proven in the sera of all vaccinees. 56% of whom demonstrated titres > or = 0.5 IU ml-1. At the same day the vaccinees were given a single booster dose of vaccine whose effect was measured 2 weeks later. With the RFFI test on day 1114, sera revealed an extraordinarily high booster response in all 44 vaccinees. The study proved the anamnestic response after a full course of rabies vaccination to be a very stable one, and the capability of a single booster dose of vaccine to evoke high-titred rabies antibody response. Of the four vaccines used in the study, under comparable conditions HDCV proved superior to PCECV PDEV and PVRV on all 3 days of serology-35, 1100 and 1114, though this difference was statistically attested only on days 35 and 1114.
authors.affiliation: Zagreb Institute of Public Health, Croatia.
authors.forename: R
authors.initials: R
authors.lastname: Vodopija
authors.forename: M
authors.initials: M
authors.lastname: Lafont
authors.forename: Z
authors.initials: Z
authors.lastname: Baklaić
authors.forename: M
authors.initials: M
authors.lastname: Ljubicić
authors.forename: M
authors.initials: M
authors.lastname: Svjetlicić
authors.forename: I
authors.initials: I
authors.lastname: Vodopija
mesh_terms: D000328:Adult; D000914:Antibodies, Viral / Q000096:biosynthesis*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007117:Immunization, Secondary; D008297:Male; D008875:Middle Aged; D009784:Occupational Diseases / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D011819:Rabies Vaccines